MGA expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.18369997032164E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.58316999999686E-05 |
Normal-vs-Stage2 |
1.368490E-04 |
Normal-vs-Stage3 |
3.10630410282897E-11 |
Normal-vs-Stage4 |
3.9386000016961E-08 |
Stage1-vs-Stage2 |
3.260000E-01 |
Stage1-vs-Stage3 |
5.434800E-04 |
Stage1-vs-Stage4 |
8.415400E-03 |
Stage2-vs-Stage3 |
2.445600E-01 |
Stage2-vs-Stage4 |
3.109400E-01 |
Stage3-vs-Stage4 |
9.481000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.13030001708859E-09 |
Normal-vs-AfricanAmerican |
1.57590000005037E-06 |
Normal-vs-Asian |
4.737800E-01 |
Caucasian-vs-AfricanAmerican |
4.026600E-01 |
Caucasian-vs-Asian |
1.891230E-01 |
AfricanAmerican-vs-Asian |
1.094840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.12060005298088E-09 |
Normal-vs-Female |
1.38520000025899E-07 |
Male-vs-Female |
8.076400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.004600E-03 |
Normal-vs-Age(41-60Yrs) |
3.66450000000018E-05 |
Normal-vs-Age(61-80Yrs) |
4.2796988175553E-11 |
Normal-vs-Age(81-100Yrs) |
4.28709999999999E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.115200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.916800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.567400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.023500E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.848300E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.292000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.208200E-01 |
Normal-vs-Grade 2 |
1.97658999999684E-05 |
Normal-vs-Grade 3 |
2.7815000303022E-09 |
Normal-vs-Grade 4 |
1.06470054994645E-10 |
Grade 1-vs-Grade 2 |
1.946820E-01 |
Grade 1-vs-Grade 3 |
3.325900E-02 |
Grade 1-vs-Grade 4 |
2.062400E-03 |
Grade 2-vs-Grade 3 |
3.243800E-02 |
Grade 2-vs-Grade 4 |
7.633400E-04 |
Grade 3-vs-Grade 4 |
5.925900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.621300E-04 |
Normal-vs-ccB subtype |
4.05839994943591E-09 |
ccA subtype-vs-ccB subtype |
3.538000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.30620000371451E-08 |
Normal-vs-N1 |
4.479500E-03 |
N0-vs-N1 |
7.520600E-01 |
|
|